Pharmacy Eva Assioti | Egkomi
|
|
Search in store
clear
filters
Featured Products
Accessories
Baby Products
Bath & Body
Candies, Pastilles, Mints & Gums
Food & Beverages
Health & Wellbeing
Make Up
Maternity
Medical Supplies / Devices
Men
Oral Care
Perfumes
Pet Supplies
Reading Glasses
Size 36
Size 36/37
Size 37
Size 38
Size 39
Size 40
Size 40/41
Size 41
Size 42
Size 42/43
Size 43
Size 44
Size 44/45
Size 45
Skin Care
Sun Care & Tanning
Treatments
Vitamins & Supplements
Woman's Care
Women's Care
Checkout
Nothing added to the cart!
Rinopanteina Nasal Ointment 10G
9.92€
RINOPANTEINA NASAL OINTMENT 10G
What Rinopanteina® is and what is used for:
Rinopanteina® is a medical device which lubricates and maintains the hydration of the nasal mucosa, helping the re-epithelization process.
Rinopanteina® is indicated:
After a surgical operation, to reduce the formation of crusts
In case of dry and/or atrophic nasal mucosa caused by particular environmental conditions, nasal sprays, aerosol therapy or temporary pathologies (i.e. rhinitis medicamentosa or allergic rhinitis, ozena)
In order to reduce the consequences of epistaxis also when caused by a traumatic event
In order to facilitate endoscopic examinations and/or tamponade maneuvers. The ointment is useful for prevention and treatment of cold-induced chapped skin around the nose.
What you need to know before you use Rinopanteina®:
Do not use this product in case of known hypersensitivity to any component of the product (listed in Section 6).
How to store Rinopanteina® - Keep out of the reach and sight of children. - It is preferable to store the product at room temperature. -
Ointment Ingredients: Vitamin A Palmitate (0.05%), D-Panthenol (5.0%), Hydrolyzed Protein (Avena Sativa extract), Sodium Hyaluronate (0.1%), Ceteareth-20, Sodium Benzoate, BHA, Mineral Oil, Petrolatum, Purified Water. Drops Ingredients: Vitamin A Palmitate (0.05%), D-Panthenol (0.1%), BHA, Mineral Oil, Petrolatum. Presentations Ointment: 10 g tube Drops: 30 ml bottle Rinopanteina® is a Medical Device according to Council Directive 93/42/EEC